Virtus LifeSci Biotech Products ETF (BBP)
NYSEARCA: BBP · Real-Time Price · USD
61.94
+0.54 (0.87%)
At close: Nov 20, 2024, 12:14 PM
61.87
-0.07 (-0.11%)
After-hours: Nov 20, 2024, 8:00 PM EST
BBP Holdings List
As of Nov 19, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | TVTX | Travere Therapeutics, Inc. | 3.67% |
2 | ADMA | ADMA Biologics, Inc. | 2.92% |
3 | TGTX | TG Therapeutics, Inc. | 2.77% |
4 | MIRM | Mirum Pharmaceuticals, Inc. | 2.41% |
5 | EXEL | Exelixis, Inc. | 2.39% |
6 | AUPH | Aurinia Pharmaceuticals Inc. | 2.32% |
7 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.24% |
8 | TARS | Tarsus Pharmaceuticals, Inc. | 2.16% |
9 | GILD | Gilead Sciences, Inc. | 2.11% |
10 | LGND | Ligand Pharmaceuticals Incorporated | 2.10% |
11 | RYTM | Rhythm Pharmaceuticals, Inc. | 2.07% |
12 | ZLAB | Zai Lab Limited | 2.03% |
13 | AXSM | Axsome Therapeutics, Inc. | 2.01% |
14 | UTHR | United Therapeutics Corporation | 1.92% |
15 | ITCI | Intra-Cellular Therapies, Inc. | 1.86% |
16 | INSM | Insmed Incorporated | 1.83% |
17 | AGIO | Agios Pharmaceuticals, Inc. | 1.78% |
18 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.77% |
19 | TBPH | Theravance Biopharma, Inc. | 1.77% |
20 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.73% |
21 | BGNE | BeiGene, Ltd. | 1.72% |
22 | INCY | Incyte Corporation | 1.72% |
23 | KNSA | Kiniksa Pharmaceuticals International, plc | 1.70% |
24 | BNTX | BioNTech SE | 1.69% |
25 | HRMY | Harmony Biosciences Holdings, Inc. | 1.67% |
26 | ACAD | ACADIA Pharmaceuticals Inc. | 1.64% |
27 | PTCT | PTC Therapeutics, Inc. | 1.63% |
28 | RARE | Ultragenyx Pharmaceutical Inc. | 1.60% |
29 | DAWN | Day One Biopharmaceuticals, Inc. | 1.60% |
30 | ROIV | Roivant Sciences Ltd. | 1.60% |
31 | DVAX | Dynavax Technologies Corporation | 1.53% |
32 | ASND | Ascendis Pharma A/S | 1.49% |
33 | KRYS | Krystal Biotech, Inc. | 1.49% |
34 | IOVA | Iovance Biotherapeutics, Inc. | 1.48% |
35 | SWTX | SpringWorks Therapeutics, Inc. | 1.48% |
36 | AMGN | Amgen Inc. | 1.43% |
37 | VRTX | Vertex Pharmaceuticals Incorporated | 1.43% |
38 | IBRX | ImmunityBio, Inc. | 1.39% |
39 | HALO | Halozyme Therapeutics, Inc. | 1.38% |
40 | YMAB | Y-mAbs Therapeutics, Inc. | 1.38% |
41 | FOLD | Amicus Therapeutics, Inc. | 1.37% |
42 | BPMC | Blueprint Medicines Corporation | 1.36% |
43 | LEGN | Legend Biotech Corporation | 1.34% |
44 | NBIX | Neurocrine Biosciences, Inc. | 1.34% |
45 | PHAT | Phathom Pharmaceuticals, Inc. | 1.31% |
46 | SRPT | Sarepta Therapeutics, Inc. | 1.30% |
47 | ESPR | Esperion Therapeutics, Inc. | 1.27% |
48 | IONS | Ionis Pharmaceuticals, Inc. | 1.25% |
49 | IMCR | Immunocore Holdings plc | 1.25% |
50 | BBIO | BridgeBio Pharma, Inc. | 1.19% |
As of Nov 19, 2024